These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 24174400)

  • 21. Examination of thermal unfolding and aggregation profiles of a series of developable therapeutic monoclonal antibodies.
    Brader ML; Estey T; Bai S; Alston RW; Lucas KK; Lantz S; Landsman P; Maloney KM
    Mol Pharm; 2015 Apr; 12(4):1005-17. PubMed ID: 25687223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring Chemical Space for New Substances to Stabilize a Therapeutic Monoclonal Antibody.
    Tosstorff A; Menzen T; Winter G
    J Pharm Sci; 2020 Jan; 109(1):301-307. PubMed ID: 31697947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matching pH values for antibody stabilization and crystallization suggest rationale for accelerated development of biotherapeutic drugs.
    Sjuts H; Schreuder H; Engel CK; Bussemer T; Gokarn Y
    Drug Dev Res; 2020 May; 81(3):329-337. PubMed ID: 31758731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physicochemical Stability of Monoclonal Antibodies: A Review.
    Le Basle Y; Chennell P; Tokhadze N; Astier A; Sautou V
    J Pharm Sci; 2020 Jan; 109(1):169-190. PubMed ID: 31465737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Orthogonal Techniques to Study the Effect of pH, Sucrose, and Arginine Salts on Monoclonal Antibody Physical Stability and Aggregation During Long-Term Storage.
    Svilenov HL; Kulakova A; Zalar M; Golovanov AP; Harris P; Winter G
    J Pharm Sci; 2020 Jan; 109(1):584-594. PubMed ID: 31689429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arginine as an Excipient for Protein Freeze-Drying: A Mini Review.
    Stärtzel P
    J Pharm Sci; 2018 Apr; 107(4):960-967. PubMed ID: 29183741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of biophysical characterization techniques in predicting monoclonal antibody stability.
    Thiagarajan G; Semple A; James JK; Cheung JK; Shameem M
    MAbs; 2016; 8(6):1088-97. PubMed ID: 27210456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of high-concentration endostatin formulation: Harmonization of excipients' contributions on colloidal and conformational stabilities.
    Wang S; Zhang X; Wu G; Tian Z; Qian F
    Int J Pharm; 2017 Sep; 530(1-2):173-186. PubMed ID: 28755991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Hydrogen Exchange Mass Spectrometry as a Stability-Indicating Method for Formulation Excipient Screening for an IgG4 Monoclonal Antibody.
    Toth RT; Pace SE; Mills BJ; Joshi SB; Esfandiary R; Middaugh CR; Weis DD; Volkin DB
    J Pharm Sci; 2018 Apr; 107(4):1009-1019. PubMed ID: 29269271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein-excipient interactions: mechanisms and biophysical characterization applied to protein formulation development.
    Kamerzell TJ; Esfandiary R; Joshi SB; Middaugh CR; Volkin DB
    Adv Drug Deliv Rev; 2011 Oct; 63(13):1118-59. PubMed ID: 21855584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macromolecular crowding: chemistry and physics meet biology (Ascona, Switzerland, 10-14 June 2012).
    Foffi G; Pastore A; Piazza F; Temussi PA
    Phys Biol; 2013 Aug; 10(4):040301. PubMed ID: 23912807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-throughput assessment of thermal and colloidal stability parameters for monoclonal antibody formulations.
    He F; Woods CE; Becker GW; Narhi LO; Razinkov VI
    J Pharm Sci; 2011 Dec; 100(12):5126-41. PubMed ID: 21789772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microfluidic Approaches for the Characterization of Therapeutic Proteins.
    Kopp MRG; Arosio P
    J Pharm Sci; 2018 May; 107(5):1228-1236. PubMed ID: 29325925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical instability of a therapeutic Fc fusion protein: domain contributions to conformational and colloidal stability.
    Fast JL; Cordes AA; Carpenter JF; Randolph TW
    Biochemistry; 2009 Dec; 48(49):11724-36. PubMed ID: 19899812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accelerated stability studies of abatacept formulations: comparison of freeze-thawing- and agitation-induced stresses.
    Cordes AA; Carpenter JF; Randolph TW
    J Pharm Sci; 2012 Jul; 101(7):2307-15. PubMed ID: 22488299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of protein conformational stability employing a multimodal spectrometer.
    Hu L; Olsen C; Maddux N; Joshi SB; Volkin DB; Middaugh CR
    Anal Chem; 2011 Dec; 83(24):9399-405. PubMed ID: 22047496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of a folding model and in situ spectroscopic techniques for rational formulation development and stability testing of monoclonal antibody therapeutics.
    Rao G; Iyer V; Kosloski MP; Pisal DS; Shin E; Middaugh CR; Balu-Iyer SV
    J Pharm Sci; 2010 Apr; 99(4):1697-706. PubMed ID: 19798762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T
    Robinson MJ; Matejtschuk P; Bristow AF; Dalby PA
    Mol Pharm; 2018 Jan; 15(1):256-267. PubMed ID: 29141152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mapping the Aggregation Kinetics of a Therapeutic Antibody Fragment.
    Chakroun N; Hilton D; Ahmad SS; Platt GW; Dalby PA
    Mol Pharm; 2016 Feb; 13(2):307-19. PubMed ID: 26692229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.